Clinical data regarding treatment in Japanese patients with T2DM showed that SGLT2 inhibitors significantly decreased heart rate in patients with high baseline HR levels (≥70/min before treatment) [38]. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.